Business Description

Sera Prognostics Inc
NAICS : 621512
SIC : 8734
Description
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, and other pregnancy complications.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 27.11 | |||||
Equity-to-Asset | 0.84 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.06 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -2.07 | |||||
Beneish M-Score | -2.02 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 65.1 | |||||
3-Year EBITDA Growth Rate | -21 | |||||
3-Year EPS without NRI Growth Rate | -14.2 | |||||
3-Year FCF Growth Rate | -0.4 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 47.25 | |||||
9-Day RSI | 43.08 | |||||
14-Day RSI | 37.86 | |||||
6-1 Month Momentum % | -49.69 | |||||
12-1 Month Momentum % | 23.94 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.54 | |||||
Quick Ratio | 4.54 | |||||
Cash Ratio | 4.5 | |||||
Days Sales Outstanding | 112.13 | |||||
Days Payable | 1762.43 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -21.7 | |||||
Shareholder Yield % | -1.39 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 30.93 | |||||
Operating Margin % | -11838.67 | |||||
Net Margin % | -11084 | |||||
ROE % | -42.04 | |||||
ROA % | -37.1 | |||||
ROIC % | -120.58 | |||||
ROC (Joel Greenblatt) % | -1435.75 | |||||
ROCE % | -41.43 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 143.33 | |||||
PB Ratio | 0.66 | |||||
Price-to-Tangible-Book | 0.67 | |||||
EV-to-EBIT | 0.14 | |||||
EV-to-EBITDA | 0.14 | |||||
EV-to-Revenue | -15.42 | |||||
EV-to-Forward-Revenue | 36.49 | |||||
EV-to-FCF | 0.2 | |||||
Price-to-Net-Current-Asset-Value | 1.11 | |||||
Price-to-Net-Cash | 1.13 | |||||
Earnings Yield (Greenblatt) % | 714.29 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SERA
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sera Prognostics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.375 | ||
EPS (TTM) ($) | -1.34 | ||
Beta | 0 | ||
Volatility % | 157.15 | ||
14-Day RSI | 37.86 | ||
14-Day ATR ($) | 0.149552 | ||
20-Day SMA ($) | 1.757 | ||
12-1 Month Momentum % | 23.94 | ||
52-Week Range ($) | 1.1 - 4.25 | ||
Shares Outstanding (Mil) | 31.28 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Sera Prognostics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Sera Prognostics Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Sera Prognostics Inc Frequently Asked Questions
What is Sera Prognostics Inc(SERA)'s stock price today?
The current price of SERA is $1.75. The 52 week high of SERA is $4.25 and 52 week low is $1.10.
When is next earnings date of Sera Prognostics Inc(SERA)?
The next earnings date of Sera Prognostics Inc(SERA) is 2023-11-09 Est..
Does Sera Prognostics Inc(SERA) pay dividends? If so, how much?
Sera Prognostics Inc(SERA) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |